In the framework of urologic oncology, mini-invasive procedures have increased the last decades particularly for urothelial carcinoma. One of the essential step in the management of this disease stay the diagnostic, which strongly impacts the treatment choice. The histopathologic evaluation of the grade of the tumor is a keystone of the diagnosis, and its recognition is not possible with a macroscopic evaluation. Nowadays, this specific intraoperative characteristic evaluation remains difficult despite the emergence of new technologies which use exogenous fluorophore. In our study, we assessed the use of an optical multimodal technique based on endogenous fluorescence combining qualitative and quantitative analysis for the diagnostic of urothelial carcinoma grades.
INTRODUCTION AND OBJECTIVES:
In the framework of urologic oncology, mini-invasive procedures have increased the last decades particularly for urothelial carcinoma. One of the essential step in the management of this disease stay the diagnostic, which strongly impacts the treatment choice. The histopathologic evaluation of the grade of the tumor is a keystone of the diagnosis, and its recognition is not possible with a macroscopic evaluation. Nowadays, this specific intraoperative characteristic evaluation remains difficult despite the emergence of new technologies which use exogenous fluorophore. In our study, we assessed the use of an optical multimodal technique based on endogenous fluorescence combining qualitative and quantitative analysis for the diagnostic of urothelial carcinoma grades.
METHODS: Urothelial samples from bladder and upper urinary tract were prospectively included (IRB-00003835) and analyzed on a specific optical multimodal setup based on endogenous fluorescence.The analysis included qualitative analyses with two-photons fluorescence imaging (TPF) and quantitative analyses with spectral analyses and fluorescence lifetime imaging (FLIM). Qualitative analyses were compared with pathological examination. Quantitative analyses was performed with a 870nm excitation wavelength, in the spectral analysis we evaluated the spectra, the redox ratio (NADH and FAD) and the fluorescence lifetime for each sample.
RESULTS: We identified 3 major urothelial aspects by TPF. All this samples were correlated with pathological examinations, and permitted to differentiate healthy tissue from low and high grade urothelial carcinoma. In the quantitative analysis, the spectral results shown that the intensity level of the emitted spectra was correlated with the histopathological characteristics: the higher the grade was, the lower was the fluorescence signal. The redox ratio analysis was significantly higher in the healthy urothelium compared with tumors samples (p<0.001). Moreover, we were able to discriminate low grade from high grade tumors, the low grade had a significantly higher redox ratio (p¼0.002). We were able to identify the cells structure in the FLIM images and to compare the different grade. This analysis also permitted to discriminate the different origins. The average lifetime in low grade tumor appeared shorter on our images and in the histogram shown significant differences between healthy, low grade and high grade urothelial carcinoma: healthy vs. low grade (p ¼ 0.002), healthy vs. high grade (p < 0.001) and high grade vs. low grade (p < 0.001).
CONCLUSIONS: Those results show that multimodal optical analysis was able to discriminate low grade from high grade urothelial carcinoma without using exogenous fluorophore. This is a promising technology for the development of an optical fiber setup designed for an intraoperative diagnosis of urothelial carcinoma in the area of endourology.
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MP54-19 DNA METHYLATION INHIBITORS COULD RE-SENSITIZE DRUG-RESISTANCE BLADDER CANCER CELLS IN VITRO AND IN VIVO
Naotaka Nishiyama*, Nobuo Shinkai, Sapporo, Japan; Stephanie Yi, Christopher E. Duymich, Los Angeles, CA; Tetsuya Shindo, Sapporo, Japan; Peter A Jones, Grand Rapids, MI; Hiromu Suzuki, Naoya Masumori, Sapporo, Japan; Gangning Liang, Los Angeles, CA INTRODUCTION AND OBJECTIVES: Aberrant DNA methylation is one of the well-known epigenetic changes in cancer, although its involvement in the chemoresistance remains to be elucidated. In this study, we aimed to unravel the roles played by DNA methylation in chemoresistance in bladder cancer (BCa) in vitro and in vivo.
METHODS: We established gemcitabine (GEM)-resistant (T24-RG and UMUC3-RG) or cisplatin (CDDP)-resistant (T24-RC and UNUC3-RC) BCa cell lines by continuously treating their parental cells. Genome-wide DNA methylation was assessed by Infinium HumanMethylation450 BeadChip (HM450). To assess the chromatin accessibilities, cells were treated with a CpG methyltransferase M.SssI, after which DNA methylation was analyzed by HM450. To evaluate whether treatment with epigenetic drugs could overcome the chemoresistance in BCa, cells were treated with a DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (5-Aza-CdR) (1mM for 24 h) after which they were treated with or without GEM or CDDP. Effects of the drug treatment on BCa cell proliferation were assessed in vitro and in vivo.
RESULTS: HM450 assays revealed increased levels of methylation at a number of CpG sites in the resistant cells as compared the parental cells (730 sites in T24-RC and 3856 sites in UMUC3-RC, respectively), respectively. A combination of 5-Aza-CdR and CDDP synergistically suppressed proliferation of CDDP-resistant BCa cells in vitro, suggesting that 5-Aza-CdR restored CDDP-sensitivity (Figure 1.  A, B) . In contrast, 5-Aza-CdR didn't show any growth inhibitory effects in GEM-resistant cells (Figure 1. C, D) . We also found that the treatment with 5-Aza-CdR strikingly suppressed tumor formation by CDDPresistant BCa cells in nude mice (Figure 2 ). Because 5-Aza-CdR alone was sufficient to completely block the xenograft formation, no synergistic effect of 5-Aza-CdR plus CDDP was observed (Figure 2) . CONCLUSIONS: Our results suggest that epigenetic alteration may be one of key factors for drug resistance, drug resistance cells could be desensitized by DNA methylation inhibitors especially in the CDDP-resistance in BCa cells.
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